3 ms·
I did not downvote, but OP failed to provide a link to back up his claim, or to make explicit what "slowing decline by about 30%" even means. In light of the f
by isolli 2y ago
I did not downvote, but OP failed to provide a link to back up his claim, or to make explicit what "slowing decline by about 30%" even means.
In light of the fraudulent and scandalous approval of aducanumab [0] (which also targeted amyloid), such claims must be thoroughly referenced.
[0] https://en.wikipedia.org/wiki/Aducanumab#Efficacy https://en.wikipedia.org/wiki/Aducanumab#Efficacy
- kraussvonespy 2y agoIf it helps, here’s info from Dr. Derek Lowe, a 30+ year pharma chemist and author of In The Pipeline. For further research on the topic, he has many other posts on the topic, some of which are linked in the links below. https://www.science.org/content/blog-post/aduhelm-again https://www.science.org/content/blog-post/aduhelm-again https://www.science.org/content/blog-post/goodbye-aduhelm https://www.science.org/content/blog-post/goodbye-aduhelm https://www.science.org/content/blog-post/alzheimer-s-and-infectious-disease-story-continues https://www.science.org/content/blog-post/alzheimer-s-and-in...